Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD) [Phase 1, Phase 2]

View source ↗

Summary

An interventional trial evaluating the safety, tolerability, and preliminary efficacy of intravenous AION-301 versus placebo in adults with chronic kidney disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• AION-301

Snippet

Sponsor: AION Healthspan, Inc. | Conditions: Chronic Kidney Disease Stage 3 | Phase 1, Phase 2 | Status: RECRUITING